AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque ...
Few researchers can claim to be a pioneer in their field quite like Teresa K. Woodruff, PhD. While serving as the basic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback